AKELOS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 28 Dec 2024)
What this means for you
Registered since 23 Jul 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88170591
- Registration number
- 5815275
- Mark type
- Stylized text
- Filed
- 26 Oct 2018
- Published for opposition
- 19 Mar 2019
- Registered
- 23 Jul 2019
- Attorney of record
- Douglas N. Masters
Goods and services
- Class 042 — Scientific and technological services: Medical research namely, clinical trial services; Pharmaceutical research and development services; biological research; chemical research; Testing of pharmaceuticals; Pharmaceutical drug development services; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the fields of pharmaceuticals and genetics
Owner
- Akelos Inc., New York, NY, US
- Akelos Inc., New York, NY, US
- Akelos Inc., New York, NY, US
Prosecution history
- 28 Dec 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 28 Dec 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 28 Dec 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Jul 2024 — TEAS SECTION 8 & 15 RECEIVED
- 23 Jul 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 21 Jun 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Jun 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Jun 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 06 Jun 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 21 May 2019 — USE AMENDMENT FILED
- 03 Jun 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 May 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 May 2019 — TEAS STATEMENT OF USE RECEIVED
- 14 May 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT